# FDA Inspection 1001620 - CXL-USA, LLC - February 17, 2017

Source: https://www.keypedia.com/records/fda_inspections/cxl-usa-llc/5b195e2b-bfc2-40de-8b1d-b317d3a5d297
Source feed: FDA_Inspections

> FDA Inspection 1001620 for CXL-USA, LLC on February 17, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1001620
- Company Name: CXL-USA, LLC
- Inspection Date: 2017-02-17
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 891633 - 2014-08-19](https://www.keypedia.com/records/fda_inspections/cxl-usa-llc/a88073f0-8b9b-4bb8-acb0-950ed3c1e9cd)

Company: https://www.keypedia.com/companies/cxl-usa-llc/e55a3c0b-21c3-4f3b-86a5-3a65888f44cf

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c